Concepedia

Michael Amdahl

MA

11

Publications

1.8K

Citations

11

H-Index

2001

Active since

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

University Medical Center Groningen

University of Groningen

Heidelberg University

Michael Amdahl is an author at Abbott Fund specializing in medicine, chronic kidney disease, and urology.

Top concepts

Publications per year

2001–2016

11

Publications

11

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

Dick de Zeeuw, Rajiv Agarwal, Michael Amdahl et al. · The Lancet · 2010 · 686 citations

, , +4

Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism

Stuart M. Sprague, Francisco Llach, Michael Amdahl et al. · Kidney International · 2003 · 384 citations

, , +1

Performance of hemodialysis with novel medium cut-off dialyzers

Alexander H. Kirsch, Raphael Lyko, Lars‐Göran Nilsson et al. · Nephrology Dialysis Transplantation · 2016 · 226 citations · Full text

Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings

D. Dobrez, Ângelo do Carmo da Silva Mathes, Michael Amdahl et al. · Nephrology Dialysis Transplantation · 2004 · 114 citations · Full text

Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study

Markus Ketteler, Kévin Martin, Myles Wolf et al. · Nephrology Dialysis Transplantation · 2012 · 99 citations · Full text

Rows per page

1–5 of 11